Financier WorldwideSeptember 2011
The article discuses the importance of investigating federal funding and collaborative agreements with the government during IP due diligence of a pharmaceutical or biotech company.
View Attachment (PDF)
(212) 218-2100 New York
(714) 540-8700 California
(202) 530-1010 Washington DC
© Copyright 2018 Fitzpatrick, Cella, Harper & Scinto. All Rights Reserved. Images are for design purposes only with actors appearing in some photos. Attorney Advertising. Prior results do not guarantee similar outcome.